4
Changes in Ownership
Phathom Pharmaceuticals, Inc. Filed Acc 0001209191-23-031647
CFO and CBO sold 2,110 shares at $12.87 ($27,165)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Henderson Molly CFO and CBO | 2023-05-22 | Sale 10b5-1 | −2,110 | $12.87 | $27,165 | 70,466 | D |
| Open-market sales · 2,110 sh · avg $12.87 · $27,165 | |||||||
Loading xslF345X04/doc4.xml…